Abstract
SHIRPA is a three-stage protocol for the comprehensive assessment of primarily mouse behavior. The first stage consists of high-throughput phenotyping of 33 behavioral observations and 7 metabolic or disease observations. We modified this part of the protocol by integrating new morphologic observations into the initial phenotype assay of behavior and dysmorphology. Behavioral observations assessed by this protocol, now referred to as the “modified-SHIRPA,” are compatible with the original “SHIRPA” protocol. Using modified-SHIRPA, we screened dominant phenotypes of more than 10,000 G1 progeny generated by crossing DBA/2J females with ENU-treated C57BL/6J males. To date, we have obtained 136 hereditary-confirmed mutants that exhibit behavioral and morphologic defects. Some independent mutant lines exhibited similar phenotypes, suggesting that they may represent alleles of the same gene or mutations in the same genetic pathway. They could hold great potential for the unraveling of the molecular mechanisms of certain phenotypes.
Similar content being viewed by others
References
Coghill EL, Hugill A, Parkinson N, Davison C, Glenister P, et al. (2002) A gene-driven approach to the identification of ENU mutants in the mouse. Nat Genet 30: 255–256
Graw J, Neuhauser-Klaus A, Loster J, Klopp N, Favor J. (2002) Ethylnitrosourea-induced base pair substitution affects splicing of the mouse gammaE-crystallin encoding gene leading to the expression of a hybrid protein and to a cataract. Genetics 161: 1633–1634
Hatcher JP, Jones DN, Rogers DC, Hatcher PD, Reavill C, et al. (2001) Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res 125: 43–47
Hitotsumachi S, Carpenter DA, Russell WL (1985) Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc Natl Acad Sci U S A 82: 6619–6621
Inoue M, Sakuraba Y, Motegi H, Kubota N, Toki H, et al. (2004) A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program. Hum Mol Genet 13: 1147–1157
Jackson IJ (1988) A cDNA encoding tyrosinase-related protein maps to the brown locus in mouse. Proc Natl Acad Sci U S A 85: 4392–4396
Kikkawa Y, Oyama A, Ishii R, Miura I, Amano T, et al. (2003) Small deletion hotspot in the type II keratin gene mK6irs1/Krt2-6g on mouse chromosome 15, a candidate for causing the wavy hair of the caracul (Ca) mutation. Genetics 165: 721–733
Masuya H, Nakai Y, Motegi H, Niinaya N, Kida Y, et al. (2004) Development and implementation of a database system to manage a large-scale mouse ENU-mutagenesis program. Mamm Genome 15: 404–411
Masuya H, Shimizu K, Sezutsu H, Sakuraba Y, Nagano J, et al. (2005) Enamelin (Enam) is essential for amelogenesis: ENU-induced mouse mutants as models for different clinical subtypes of human amelogenesis imperfecta (AI). Hum Mol Genet 14: 575–583
Mercer JA, Seperack PK, Strobel MC, Copeland NG, Jenkins NA (1991) Novel myosin heavy chain encoded by murine dilute coat colour locus. Nature. 349: 709–713
Nolan PM, Kapfhamer D, Bucan M (1997) Random mutagenesis screen for dominant behavioral mutations in mice. Methods 13: 379–395
Nolan PM, Peters J, Vizor L, Strivens M, Washbourne R, et al. (2000) Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource. Mamm Genome 11: 500–506
Norreel JC, Jamon M, Riviere G, Passage E, Fontes M, et al. (2001) Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur J Neurosci 13: 1625–1634
Rafael JA, Nitta Y, Peters J, Davies KE (2000) Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. Mamm Genome 11: 725–728
Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, et al. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8: 711–713
Rogers DC, Jones DN, Nelson PR, Jones CM, Quilter CA, et al. (1999) Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 105, 207–217
Rogers DC, Peters J, Martin JE, Ball S, Nicholson SJ, et al. (2001) SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. Neurosci Lett 22: 89–92
Russell LB, Bangham JW, Stelzner KF, Hunsicker PR (1988) High frequency of mosaic mutants produced by N-ethyl-N-nitrosourea exposure of mouse zygotes. Proc Natl Acad Sci U S A 85: 9167–9170
Shibahara S, Tomita Y, Yoshizawa M, Shibata K, Tagami H (1992) Identification of mutations in the pigment cell-specific gene located at the brown locus in mouse. Pigment Cell Res Suppl 2: 90–95
Tsugane M, Yasuda M (1995) Dermatoglyphics on volar skin of mice: the normal pattern. Anat Rec 242, 225–232
Acknowledgments
The authors thank Dr. Patrick M. Nolan for information about the detailed criteria of the SHIRPA protocol and for helpful advice during the preparation of the article. They thank the technical staff of the Mouse Functional Genomics Research Group of RIKEN GSC for animal care taking and phenotype screening. This study was supported in part by National Bioresources Project of the Ministry of Education, culture, sports, science and technology of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masuya, H., Inoue, M., Wada, Y. et al. Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program. Mamm Genome 16, 829–837 (2005). https://doi.org/10.1007/s00335-005-2430-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-005-2430-8